Literature DB >> 22372856

Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.

J-S Bae1, W Lee, A R Rezaie.   

Abstract

BACKGROUND: Recent results have indicated that polyphosphate, released by activated platelets, can function as a procoagulant to modulate the proteolytic activity of serine proteases of the blood clotting cascade.
OBJECTIVE: To determine whether polyphosphate is involved in inducing signal transduction in cellular and animal models.
METHODS: The effect of polyphosphate on human umbilical vein endothelial cells was examined by monitoring cell permeability, apoptosis and activation of NF-κB after treating cells with different concentrations of polyphosphate. Moreover, the expression of cell surface adhesion molecules (VCAM-1, ICAM-1 and E-selectin) and the adhesion of THP-1 cells to polyphosphate-treated cells were monitored using established methods. In the in vivo model, the pro-inflammatory effect of polyphosphate was assessed by monitoring vascular permeability and migration of leukocytes to the peritoneal cavity of mice injected with polyphosphate.
RESULTS: Polyphosphate, comprised of 45, 65 and 70 phosphate units, enhanced the barrier permeability and apoptosis in cultured endothelial cells and up-regulated the expression of cell adhesion molecules, thereby mediating the adhesion of THP-1 cells to polyphosphate-treated endothelial cells. These effects of polyphosphate were mediated through the activation of NF-κB and could not be recapitulated by another anionic polymer, heparin. Polyphosphate also increased the extravasation of the bovine serum albumin (BSA)-bound Evans blue dye and the migration of leukocytes to the mouse peritoneal cavity, which was prevented when activated protein C (APC) was intravenously (i.v.) injected 2 h before the challenge.
CONCLUSION: Polyphosphate, in addition to up-regulation of coagulation, can elicit potent pro-inflammatory responses through the activation of NF-κB, possibly contributing to the pro-inflammatory effect of activated platelets.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372856      PMCID: PMC3366017          DOI: 10.1111/j.1538-7836.2012.04671.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  30 in total

1.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

2.  Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

3.  Polyphosphate exerts differential effects on blood clotting, depending on polymer size.

Authors:  Stephanie A Smith; Sharon H Choi; Rebecca Davis-Harrison; Jillian Huyck; John Boettcher; Chad M Rienstra; Chad M Reinstra; James H Morrissey
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

4.  Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.

Authors:  V H Thourani; S S Brar; T P Kennedy; L R Thornton; J A Watts; R S Ronson; Z Q Zhao; A L Sturrock; J R Hoidal; J Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

5.  Activated protein C inhibits high mobility group box 1 signaling in endothelial cells.

Authors:  Jong-Sup Bae; Alireza R Rezaie
Journal:  Blood       Date:  2011-08-17       Impact factor: 22.113

6.  Polyphosphate is a cofactor for the activation of factor XI by thrombin.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

7.  Polyphosphate binds with high affinity to exosite II of thrombin.

Authors:  N J Mutch; T Myles; L L K Leung; J H Morrissey
Journal:  J Thromb Haemost       Date:  2009-12-11       Impact factor: 5.824

8.  Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate.

Authors:  Toshikazu Shiba; Daisuke Nishimura; Yumi Kawazoe; Yuichiro Onodera; Kaori Tsutsumi; Rie Nakamura; Minako Ohshiro
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

9.  Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Barbara M Mueller; Wolfram Ruf
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

10.  Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.

Authors:  Felicitas Müller; Nicola J Mutch; Wolfdieter A Schenk; Stephanie A Smith; Lucie Esterl; Henri M Spronk; Stefan Schmidbauer; William A Gahl; James H Morrissey; Thomas Renné
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

View more
  51 in total

1.  Emodin-6-O-β-D--glucoside inhibits high-glucose-induced vascular inflammation.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Doohyun Lee; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

2.  2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

Review 3.  From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation.

Authors:  Amanda Bentley-DeSousa; Michael Downey
Journal:  Curr Genet       Date:  2018-06-07       Impact factor: 3.886

4.  Orientin inhibits high glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice.

Authors:  Esther J Cooke; Jenny Y Zhou; Tine Wyseure; Shweta Joshi; Vikas Bhat; Donald L Durden; Laurent O Mosnier; Annette von Drygalski
Journal:  Thromb Haemost       Date:  2018-05-30       Impact factor: 5.249

6.  Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.

Authors:  Sae-Kwang Ku; Wei Zhou; Wonhwa Lee; Min-Su Han; MinKyun Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

7.  Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.

Authors:  Hayoung Yoo; Sae-Kwang Ku; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

8.  Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.

Authors:  L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2014-02-13       Impact factor: 5.249

Review 9.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  Vascular barrier protective effects of piperlonguminine in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2014-01-29       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.